192 related articles for article (PubMed ID: 22211329)
1. Correction and clarification regarding AFX and pleomorphic dermal sarcoma.
McCalmont TH
J Cutan Pathol; 2012 Jan; 39(1):8. PubMed ID: 22211329
[No Abstract] [Full Text] [Related]
2. AFX: what we now know.
McCalmont TH
J Cutan Pathol; 2011 Nov; 38(11):853-6. PubMed ID: 21955311
[No Abstract] [Full Text] [Related]
3. Atypical fibroxanthoma.
Weedon D; Van Deurse M
J Cutan Pathol; 2012 May; 39(5):565. PubMed ID: 22443422
[No Abstract] [Full Text] [Related]
4. I double dare me.
McCalmont TH
J Cutan Pathol; 2012 Jan; 39(1):5-7. PubMed ID: 22211328
[No Abstract] [Full Text] [Related]
5. Red is dead.
McCalmont TH
J Cutan Pathol; 2012 Mar; 39(3):315-6. PubMed ID: 22335589
[No Abstract] [Full Text] [Related]
6. Atypical fibroxanthoma.
Ziemer M
J Dtsch Dermatol Ges; 2012 Aug; 10(8):537-50. PubMed ID: 22709412
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic spindle cell dermal neoplasm with dot-like keratin reactivity: keratin-positive AFX or carcinoma?
Ellis R; Chase E; Barland A; Rajpara A; Fraga GR
J Cutan Pathol; 2015 Nov; 42(11):847-52. PubMed ID: 26041010
[TBL] [Abstract][Full Text] [Related]
8. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.
Folpe AL; Cooper K
Arch Pathol Lab Med; 2007 Oct; 131(10):1517-24. PubMed ID: 17922587
[TBL] [Abstract][Full Text] [Related]
9. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
[TBL] [Abstract][Full Text] [Related]
11. Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
Ricci C; De Leo A; Dika E; Lambertini M; Veronesi G; Corti B
Acta Histochem; 2020 Feb; 122(2):151498. PubMed ID: 31889532
[TBL] [Abstract][Full Text] [Related]
12. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic Dermal Sarcoma.
Saleh JS; Whittington CP; Bresler SC; Patel RM
Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
[TBL] [Abstract][Full Text] [Related]
14. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
15. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
Wieland CN; Dyck R; Weenig RH; Comfere NI
J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
[TBL] [Abstract][Full Text] [Related]
16. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma.
Anders IM; Schimmelpfennig C; Wiedemann K; Löffler D; Kämpf C; Blumert C; Reiche K; Kunz M; Anderegg U; Simon JC; Ziemer M
J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902
[TBL] [Abstract][Full Text] [Related]
17. Malignant fibrous histiocytoma, malignant melanoma and squamous cell carcinoma arising from different areas in an adult.
Kurt M; Kilickap S; Aksoy S; Tekuzman G
South Med J; 2005 Dec; 98(12):1228-9. PubMed ID: 16440931
[No Abstract] [Full Text] [Related]
18. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
[TBL] [Abstract][Full Text] [Related]
19. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
20. Reconsidering the diagnostic and prognostic utility of LN-2 for undifferentiated pleomorphic sarcoma and atypical fibroxanthoma.
Hollmig ST; Rieger KE; Henderson MT; West RB; Sundram UN
Am J Dermatopathol; 2013 Apr; 35(2):176-9. PubMed ID: 23000905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]